# Edison International: financial statements, quarterly EIX · NYSE · CIK 827052 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/eix.md) · [Financials](/companies/eix/financials.md) · [Filings](/companies/eix/filings.md) · [Insiders](/companies/eix/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eix/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [4,702](/filings/0000827052-24-000075.md) | [3,706 d](/filings/0000827052-26-000012.md) | [4,078](/filings/0000827052-25-000043.md) | [4,336](/filings/0000827052-25-000074.md) | [5,201](/filings/0000827052-25-000100.md) | [3,984 d](/filings/0000827052-26-000012.md) | [3,811](/filings/0000827052-26-000042.md) | [4,543](/filings/0000827052-25-000074.md) | [5,750](/filings/0000827052-26-000073.md) | [5,213 d](/filings/0000827052-26-000012.md) | [4,103](/filings/0000827052-26-000042.md) | [4,886](/filings/0000827052-26-000073.md) | | Operating income | $m | [492](/filings/0000827052-24-000075.md) | [791 d](/filings/0000827052-26-000012.md) | [245](/filings/0000827052-25-000043.md) | [900](/filings/0000827052-25-000074.md) | [995](/filings/0000827052-25-000100.md) | [790 d](/filings/0000827052-26-000012.md) | [2,134](/filings/0000827052-26-000042.md) | [775](/filings/0000827052-25-000074.md) | [1,432](/filings/0000827052-26-000073.md) | [2,752 d](/filings/0000827052-26-000012.md) | [1,074](/filings/0000827052-26-000042.md) | [980](/filings/0000827052-26-000073.md) | | Interest expense | $m | [433](/filings/0000827052-24-000075.md) | [426 d](/filings/0000827052-24-000013.md) | [444](/filings/0000827052-24-000035.md) | [480](/filings/0000827052-24-000055.md) | [477](/filings/0000827052-24-000075.md) | [468 d](/filings/0000827052-26-000012.md) | [301](/filings/0000827052-26-000042.md) | [504](/filings/0000827052-25-000074.md) | [488](/filings/0000827052-26-000073.md) | [246 d](/filings/0000827052-26-000012.md) | [524](/filings/0000827052-26-000042.md) | [545](/filings/0000827052-26-000073.md) | | Income tax | $m | [(23.0)](/filings/0000827052-24-000075.md) | [67.0 d](/filings/0000827052-26-000012.md) | [(113)](/filings/0000827052-25-000043.md) | [59.0](/filings/0000827052-25-000074.md) | [68.0](/filings/0000827052-25-000100.md) | [3.0 d](/filings/0000827052-26-000012.md) | [448](/filings/0000827052-26-000042.md) | [(14.0)](/filings/0000827052-25-000074.md) | [175](/filings/0000827052-26-000073.md) | [682 d](/filings/0000827052-26-000012.md) | [101](/filings/0000827052-26-000042.md) | [(203)](/filings/0000827052-26-000073.md) | | Net income | $m | [212](/filings/0000827052-24-000075.md) | [211 d](/filings/0000827052-26-000012.md) | [(11.0)](/filings/0000827052-25-000043.md) | [439](/filings/0000827052-25-000074.md) | [516](/filings/0000827052-25-000100.md) | [340 d](/filings/0000827052-26-000012.md) | [1,436](/filings/0000827052-26-000042.md) | [343](/filings/0000827052-25-000074.md) | [832](/filings/0000827052-26-000073.md) | [1,848 d](/filings/0000827052-26-000012.md) | [531](/filings/0000827052-26-000042.md) | [724](/filings/0000827052-26-000073.md) | | Diluted EPS | $ per share | [0.40](/filings/0000827052-24-000075.md) | not reported | [(0.03)](/filings/0000827052-25-000043.md) | [1.13](/filings/0000827052-25-000074.md) | [1.32](/filings/0000827052-25-000100.md) | not reported | [3.72](/filings/0000827052-26-000042.md) | [0.89](/filings/0000827052-25-000074.md) | [2.16](/filings/0000827052-26-000073.md) | not reported | [1.37](/filings/0000827052-26-000042.md) | [1.87](/filings/0000827052-26-000073.md) | | Basic EPS | $ per share | [0.40](/filings/0000827052-24-000075.md) | not reported | [(0.03)](/filings/0000827052-25-000043.md) | [1.14](/filings/0000827052-25-000074.md) | [1.33](/filings/0000827052-25-000100.md) | not reported | [3.73](/filings/0000827052-26-000042.md) | [0.89](/filings/0000827052-25-000074.md) | [2.16](/filings/0000827052-26-000073.md) | not reported | [1.38](/filings/0000827052-26-000042.md) | [1.88](/filings/0000827052-26-000073.md) | - Revenue: us-gaap:Revenues - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | period not labelled (2026-06-30) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $bn | [0.3](/filings/0000827052-25-000022.md) | [1.0](/filings/0000827052-24-000035.md) | [0.5](/filings/0000827052-24-000055.md) | [0.2](/filings/0000827052-24-000075.md) | [0.2](/filings/0000827052-26-000012.md) | [1.3](/filings/0000827052-25-000043.md) | [0.1](/filings/0000827052-25-000074.md) | [0.4](/filings/0000827052-25-000100.md) | [0.2](/filings/0000827052-26-000073.md) | [0.2](/filings/0000827052-26-000042.md) | not reported | [0.2](/filings/0000827052-26-000073.md) | | Current assets | $bn | [6.8](/filings/0000827052-25-000022.md) | [7.9](/filings/0000827052-24-000035.md) | [8.5](/filings/0000827052-24-000055.md) | [7.4](/filings/0000827052-24-000075.md) | [7.2](/filings/0000827052-26-000012.md) | [7.4](/filings/0000827052-25-000043.md) | [7.0](/filings/0000827052-25-000074.md) | [7.7](/filings/0000827052-25-000100.md) | [7.7](/filings/0000827052-26-000073.md) | [7.2](/filings/0000827052-26-000042.md) | not reported | [7.3](/filings/0000827052-26-000073.md) | | Total assets | $bn | [81.8](/filings/0000827052-25-000022.md) | [83.6](/filings/0000827052-24-000035.md) | [84.8](/filings/0000827052-24-000055.md) | [84.7](/filings/0000827052-24-000075.md) | [85.6](/filings/0000827052-26-000012.md) | [88.4](/filings/0000827052-25-000043.md) | [88.8](/filings/0000827052-25-000074.md) | [90.5](/filings/0000827052-25-000100.md) | [94.0](/filings/0000827052-26-000073.md) | [94.5](/filings/0000827052-26-000042.md) | not reported | [96.9](/filings/0000827052-26-000073.md) | | Current liabilities | $bn | [8.6](/filings/0000827052-25-000022.md) | [7.9](/filings/0000827052-24-000035.md) | [8.3](/filings/0000827052-24-000055.md) | [8.5](/filings/0000827052-24-000075.md) | [8.4](/filings/0000827052-26-000012.md) | [7.8](/filings/0000827052-25-000043.md) | [8.0](/filings/0000827052-25-000074.md) | [9.4](/filings/0000827052-25-000100.md) | [10.5](/filings/0000827052-26-000073.md) | [9.7](/filings/0000827052-26-000042.md) | not reported | [9.5](/filings/0000827052-26-000073.md) | | Total liabilities | $bn | [63.8](/filings/0000827052-25-000022.md) | [66.0](/filings/0000827052-24-000035.md) | [67.0](/filings/0000827052-24-000055.md) | [66.6](/filings/0000827052-24-000075.md) | [67.8](/filings/0000827052-26-000012.md) | [69.6](/filings/0000827052-25-000043.md) | [70.0](/filings/0000827052-25-000074.md) | [71.2](/filings/0000827052-25-000100.md) | [74.8](/filings/0000827052-26-000073.md) | [75.6](/filings/0000827052-26-000042.md) | not reported | [77.4](/filings/0000827052-26-000073.md) | | Long-term debt | $bn | [30.3](/filings/0000827052-25-000022.md) | [32.6](/filings/0000827052-24-000035.md) | [33.1](/filings/0000827052-24-000055.md) | [32.3](/filings/0000827052-24-000075.md) | [33.5](/filings/0000827052-26-000012.md) | [35.4](/filings/0000827052-25-000043.md) | [35.0](/filings/0000827052-25-000074.md) | [34.5](/filings/0000827052-25-000100.md) | [36.1](/filings/0000827052-26-000073.md) | [37.3](/filings/0000827052-26-000042.md) | not reported | [39.0](/filings/0000827052-26-000073.md) | | Current portion of debt | $bn | [2.7](/filings/0000827052-25-000022.md) | [2.1](/filings/0000827052-24-000035.md) | [1.7](/filings/0000827052-24-000055.md) | [2.5](/filings/0000827052-24-000075.md) | [2.0](/filings/0000827052-26-000012.md) | [3.0](/filings/0000827052-25-000043.md) | [2.7](/filings/0000827052-25-000074.md) | [1.9](/filings/0000827052-25-000100.md) | [1.9](/filings/0000827052-26-000073.md) | [3.0](/filings/0000827052-26-000042.md) | not reported | [1.8](/filings/0000827052-26-000073.md) | | Short-term borrowings | $bn | [1.1](/filings/0000827052-25-000022.md) | [0.8](/filings/0000827052-24-000035.md) | [1.5](/filings/0000827052-24-000055.md) | [0.6](/filings/0000827052-24-000075.md) | [1.0](/filings/0000827052-26-000012.md) | [0.0](/filings/0000827052-25-000043.md) | [0.7](/filings/0000827052-25-000074.md) | [1.9](/filings/0000827052-25-000100.md) | [2.4](/filings/0000827052-26-000073.md) | [1.2](/filings/0000827052-26-000042.md) | not reported | [0.8](/filings/0000827052-26-000073.md) | | Shareholders' equity | $bn | [15.5](/filings/0000827052-25-000022.md) | [15.2](/filings/0000827052-24-000035.md) | [15.4](/filings/0000827052-24-000055.md) | [15.7](/filings/0000827052-24-000075.md) | [15.6](/filings/0000827052-26-000012.md) | [16.6](/filings/0000827052-25-000043.md) | [16.7](/filings/0000827052-25-000074.md) | [17.2](/filings/0000827052-25-000100.md) | [17.6](/filings/0000827052-26-000073.md) | [17.3](/filings/0000827052-26-000042.md) | [19.1](/filings/0000827052-26-000073.md) | [17.9](/filings/0000827052-26-000073.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebtNoncurrent - Current portion of debt: us-gaap:LongTermDebtCurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ## Cash flow | Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [802 d](/filings/0000827052-24-000055.md) | [1,834 d](/filings/0000827052-24-000075.md) | [855 d](/filings/0000827052-26-000012.md) | [1,043](/filings/0000827052-25-000043.md) | [329 d](/filings/0000827052-25-000074.md) | [2,472 d](/filings/0000827052-25-000100.md) | [1,170 d](/filings/0000827052-26-000012.md) | [1,224](/filings/0000827052-26-000042.md) | [882 d](/filings/0000827052-25-000074.md) | [2,122 d](/filings/0000827052-26-000073.md) | [1,572 d](/filings/0000827052-26-000012.md) | [1,427](/filings/0000827052-26-000042.md) | | Capital expenditure | $m | [1,387 d](/filings/0000827052-24-000055.md) | [1,280 d](/filings/0000827052-24-000075.md) | [1,457 d](/filings/0000827052-26-000012.md) | [1,279](/filings/0000827052-25-000043.md) | [1,421 d](/filings/0000827052-25-000074.md) | [1,511 d](/filings/0000827052-25-000100.md) | [1,496 d](/filings/0000827052-26-000012.md) | [1,408](/filings/0000827052-26-000042.md) | [1,712 d](/filings/0000827052-25-000074.md) | [1,504 d](/filings/0000827052-26-000073.md) | [1,891 d](/filings/0000827052-26-000012.md) | [1,539](/filings/0000827052-26-000042.md) | | Dividends paid | $m | [278 d](/filings/0000827052-24-000055.md) | [278 d](/filings/0000827052-24-000075.md) | [279 d](/filings/0000827052-26-000012.md) | [295](/filings/0000827052-25-000043.md) | [300 d](/filings/0000827052-25-000074.md) | [301 d](/filings/0000827052-25-000100.md) | [302 d](/filings/0000827052-26-000012.md) | [319](/filings/0000827052-26-000042.md) | [318 d](/filings/0000827052-25-000074.md) | [318 d](/filings/0000827052-26-000073.md) | [319 d](/filings/0000827052-26-000012.md) | [338](/filings/0000827052-26-000042.md) | | Share repurchases | $m | not reported | not reported | not reported | [0.0](/filings/0000827052-25-000043.md) | [0.0 d](/filings/0000827052-25-000074.md) | [0.0 d](/filings/0000827052-25-000100.md) | [200 d](/filings/0000827052-26-000012.md) | [29.0](/filings/0000827052-26-000042.md) | [0.0 d](/filings/0000827052-25-000074.md) | [3.0 d](/filings/0000827052-26-000073.md) | [0.0 d](/filings/0000827052-26-000012.md) | [26.0](/filings/0000827052-26-000042.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividendsCommonStock - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q3 FY2026 (2026-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [383](/filings/0000827052-23-000084.md) | [384](/filings/0000827052-24-000035.md) | [385](/filings/0000827052-24-000055.md) | [385](/filings/0000827052-24-000075.md) | [385](/filings/0000827052-25-000043.md) | [388](/filings/0000827052-25-000074.md) | [390](/filings/0000827052-25-000100.md) | [386](/filings/0000827052-26-000042.md) | [386](/filings/0000827052-25-000074.md) | [386](/filings/0000827052-26-000073.md) | [387](/filings/0000827052-26-000042.md) | [387](/filings/0000827052-26-000073.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 384,787,221 at 2026-10-22, from the cover of the [10-Q filed 2026-10-29](/filings/0000827052-26-000073.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 11:47 ET. No prices; not investment advice.